Author:
Cheon Jae Yeon,Mozersky Jessica,Cook-Deegan Robert
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine
Reference84 articles.
1. Lindor NM, Guidugli L, Wang X, Vallée MP, Monteiro ANA, Tavtigian S, Goldgar DE, Couch FJ: A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat. 2012, 33: 8-21. 10.1002/humu.21627.
2. Eggington JM, Bowles K, Moyes K, Manley S, Esterling L, Sizemore S, Rosenthal E, Theisen A, Saam J, Arnell C: A comprehensive laboratory‐based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet. 2014, 86: 229-237. 10.1111/cge.12315.
3. Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP: Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014, 311: 1035-1045. 10.1001/jama.2014.1717.
4. Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE: Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014, 32: 2001-2009. 10.1200/JCO.2013.53.6607.
5. Futreal PA, Wooster RF, Ashworth A, Stratton MR. Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof. UK Patent GB 2307477 A. Filed 25 November, 1996; issued 29 May, 1997. ,
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献